Month: March 2023

Verizon offers relief to customers most impacted by recent Southern storms

Written by Customer Service on March 29, 2023. Posted in Public Companies.

Talk/Text/Data usage incurred from March 26 – April 26 for postpaid customers will be waived for those most impacted by the storms For media: we have b-roll, pictures and additional information on our emergency response equipment available at our Emergency Resource Center – https://www.verizon.com/about/news/emergency-resource-center What you need to know:Verizon is waiving call/text/data usage incurred for postpaid consumer and small business customers in parts of Mississippi most affected by the recent tornado outbreaks Customers whose bill cycle has already closed will have overages automatically credited backJACKSON, Miss., March 29, 2023 (GLOBE NEWSWIRE) — Following multiple days of severe weather and damaging tornadoes, Verizon is waiving postpaid call/text/data usage incurred from March 26 to April 26 for...

Standard Lithium Reminds Shareholders of Upcoming Annual General Meeting on April 4th

Written by Customer Service on March 29, 2023. Posted in Public Companies.

Shareholders Invited to View Meeting in Person in El Dorado, Arkansas EL DORADO, Ark., March 29, 2023 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, reminds shareholders that its annual general and special meeting (the “Meeting”) will be held at 10:00am (Pacific Time) on April 4, 2023. This year the Meeting will be held in a virtual format via a live webcast accessible to shareholders online through the link provided in the Meeting notice. In addition to the virtual meeting, the Company is inviting shareholders to view the Meeting in person at the First Financial Hall located in the Murphy Arts District in downtown El Dorado, Arkansas at 101 Locust Street, El Dorado, Arkansas. The Company will be streaming the...

Semantix Announces Increase in Stock Repurchase Plan by $5 million

Written by Customer Service on March 29, 2023. Posted in Public Companies.

SÃO PAULO, Brazil, March 29, 2023 (GLOBE NEWSWIRE) — Semantix, Inc. (NASDAQ: STIX), Latin America’s first fully integrated data and enterprise AI platform, today announced that its Board of Directors has authorized an increase in the Company’s existing stock repurchase plan approved by the Board in November 2022 from up to $5 million to a total of up to $10 million. The ordinary shares repurchases may be effected through open market purchases, including through the use of Rule 10b5-1 trading plans, or privately negotiated transactions. The open market repurchases will be made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, subject to market conditions, applicable legal requirements and other factors. The timing and amount of ordinary shares repurchases made pursuant to the repurchase program are subject...

Goldcliff Closes First Tranche of Private Placement

Written by Customer Service on March 29, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) — Goldcliff Resource Corporation (“Goldcliff” or the “Company”) (GCN: TSX.V, GCFFF: OTCBB PINKS) is pleased to announce the closing of the first tranche of its previously announced non-brokered private placement (“Private Placement”) consisting of (i) 2,200,000 units (each, a “NFT Unit”) for gross proceeds of $110,000; and (ii) 1,296,666 flow-through shares (each, a “FT Share”) for gross proceeds of $77,800. The Company expects the second tranche of the Private Placement to close on or before April 14, 2023. Each NFT Unit is comprised of one common share of the Company (each, a “Common Share”) and one half of one non-transferrable Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder to acquire an additional Common Share...

BioPorto Announces Financial Guidance for 2023

Written by Customer Service on March 29, 2023. Posted in Public Companies.

March 29, 2023Announcement no. 3 BioPorto Announces Financial Guidance for 2023 COPENHAGEN, Denmark and BOSTON, MA, USA, March 29, 2023, (GLOBE NEWSWIRE) — BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) announces financial guidance for 2023. BioPorto’s three strategic activities in 2023 are to:Grow revenues in European and other markets that accept CE Mark Focus on the US NGAL test’s regulatory pathway Expand the total addressable market for NGAL testsKey assumptions relating to the 2023 outlook are as follows:Assumes minimal growth in NGAL test revenues in the US during the US Food and Drug Administration (FDA) review process, and since the timing for an approval is unknown, BioPorto is not including any post-approval revenue in its outlook. While FDA approval is pending, costs related to future clinical studies are assumed...

Aerovate Therapeutics Announces Full-Year 2022 Financial Results and Business Highlights

Written by Customer Service on March 29, 2023. Posted in Earnings Releases And Operating Results.

Progress continued on the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH)Expanded intellectual property portfolio with four issued patents in 2022Management team strengthened and expanded in 2022Sufficiently funded into second half of 2025WALTHAM, Mass., March 29, 2023 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced financial results for the year ended December 31, 2022, and recent business highlights. “Aerovate had a productive year in 2022 as evidenced by the progress made with our lead pipeline candidate AV-101 and strategic additions to our management team,” said Tim Noyes, Chief...

Amendment to the March 28, 2023, News Release: Liberty Gold Reports Year-End 2022 Financial and Operating Results

Written by Customer Service on March 29, 2023. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”) is issuing an amendment to the news release issued on March 28, 2023, to restate the working capital number for the year ended December 31, 2022 from $25,200 thousand in the previous release to $17,668 thousand. The associated financial statements of the Company are not impacted by this change. The updated and amended table is below. The information in the tables below is presented in US$000s: As at December 31 2022 2021 2020Cash and short-term investments $19,813 $17,255 $16,832Working capital $17,668 $13,691 $17,977Total assets $47,954 $53,329 $60,394Current liabilities $2,543 $9,885 $6,007Non-current liabilities $2,812 $3,116 $2,137Shareholders’...

Mustang Bio Reports Full-Year 2022 Financial Results and Recent Corporate Highlights

Written by Customer Service on March 29, 2023. Posted in Earnings Releases And Operating Results.

WORCESTER, Mass., March 29, 2023 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the full year ended December 31, 2022. Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, “In 2022, we advanced our cell and gene therapy programs and presented promising research supporting the potential of our clinical portfolio at several prestigious medical meetings. Our lead clinical candidate is MB-106, a CD20-targeted, autologous CAR T cell therapy to treat relapsed or refractory B-cell non-Hodgkin lymphomas (“B-NHL”) and chronic...

Concentrix Reports First Quarter 2023 Results

Written by Customer Service on March 29, 2023. Posted in Earnings Releases And Operating Results.

NEWARK, Calif., March 29, 2023 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a leading global provider of customer experience (CX) solutions and technology, today announced financial results for the fiscal first quarter ended February 28, 2023. Three Months Ended February 28, 2023 February 28, 2022 ChangeRevenue ($M) $ 1,636.4 $ 1,536.1 6.5%Operating income ($M) $ 156.0 $ 147.7 5.6%Non-GAAP operating income ($M) (1) $ 217.6 $ 201.9 7.8%Operating margin 9.5 % 9.6 % -10 bpsNon-GAAP operating margin (1) 13.3 % 13.1 % 20 bpsNet income ($M) $ 87.9 $ 110.3 (20.3)%Non-GAAP net income ($M) (1) $ 134.0 $ 150.7 (11.1)%Adjusted EBITDA ($M) (1) $ 255.8 $ 237.9 7.5%Adjusted EBITDA margin (1) 15.6 % 15.5 % 10 bpsDiluted...

Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Written by Customer Service on March 29, 2023. Posted in Earnings Releases And Operating Results.

Positive topline data from BDC-1001 dose-escalation clinical study validates the ability of the Boltbody™ ISAC platform to generate anti-tumor activity with acceptable safety BDC-1001 advances into a focused Phase 2 program commencing in 2023: a trial as monotherapy and in combination with nivolumab in colorectal, endometrial, and gastroesophageal cancers; and a second trial in breast cancer studying monotherapy and combination with pertuzumab (Perjeta®) BDC-3042 expected to enter clinic in 2023; upcoming presentation at AACR 2023 Cash balance of $192.8 million anticipated to fund key milestones through 2025REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals